Masuda Y, Karasawa T
Department of Pharmacology, Dainippon Pharmaceutical Co., Ltd., Suita/Oska, Japan.
Arzneimittelforschung. 1993 Apr;43(4):416-8.
We examined the relative potencies of zonisamide (CAS 68291-97-4) to acetazolamide in inhibiting carbonic anhydrases in human erythrocytes and purified human carbonic anhydrase I and II in vitro and found them to be about 1/150, 1/8 and 1/188, respectively. The IC50 values of zonisamide and acetazolamide for the inhibition of erythrocyte enzymes were close to those of purified carbonic anhydrase II. This result indicates that zonisamide actually differs from acetazolamide in their actions on the physiological events which are coupled with CO2 hydration in vivo.
我们在体外检测了唑尼沙胺(化学物质登记号68291 - 97 - 4)与人红细胞中的碳酸酐酶以及纯化的人碳酸酐酶I和II相比,抑制碳酸酐酶的相对效价,发现它们分别约为1/150、1/8和1/188。唑尼沙胺和乙酰唑胺抑制红细胞酶的IC50值与纯化的碳酸酐酶II的IC50值相近。这一结果表明,唑尼沙胺与乙酰唑胺在体内对与CO2水合作用相关的生理过程的作用实际上存在差异。